article thumbnail

Current and novel biomarkers in cardiogenic shock

European Journal of Heart Failure

A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end-organ dysfunction.

article thumbnail

Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients

Frontiers in Cardiovascular Medicine

IntroductionDepression is a significant comorbidity linked to poor subjective and objective health outcomes in cardiac patients. The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT-proBNP).

article thumbnail

Elevated serum asprosin and ANGPTL8 gene expression as novel biomarkers for the diagnosis and prognosis of acute coronary syndrome

Frontiers in Cardiovascular Medicine

Identifying novel biomarkers is crucial to improving early detection and patient classification. Future studies should focus on their integration into clinical practice for enhanced patient outcomes. ng/ml) compared to healthy individuals (3.821.20 ng/ml, P<0.001).

article thumbnail

Embolic risk management in infective endocarditis: predicting the 'embolic roulette

Open Heart

EE from vegetation rupture are frequent, occurring in more than 50% of patients and can lead to ischaemic stroke and systemic organ infarctions, contributing to poor patient outcomes.

article thumbnail

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Heart BMJ

Background We evaluated the potential of circulating bone morphogenetic protein 10 (BMP10) as a biomarker for atrial stress and remodelling in patients with heart failure (HF), in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP). We also assessed the predictive value of BMP10 for adverse clinical outcomes.

article thumbnail

Biomarkers for IgAN

HCPLive

Panelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.

article thumbnail

Complexity of coronary artery disease and the release of cardiac biomarkers after CABG

Frontiers in Cardiovascular Medicine

Objective In patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release. Preoperatively, higher levels of cardiac biomarkers were found in patients with higher SYNTAX Score II.